DCM Shriram FY26 Consolidated PAT Rises 42% to Rs 855.98 Crore on Revenue Growth

DCM Shriram Limited reported a consolidated profit after tax (PAT) of Rs 855.98 crores for the financial year ended March 31, 2026, a significant increase from Rs 604.27 crores in the previous year. The Board of Directors, at its meeting held on May 13, 2026, approved the audited standalone and consolidated financial results. The statutory auditor, Deloitte Haskins & Sells, issued an unmodified audit opinion on the results. Consolidated PAT attributable to owners of the company stood at Rs 853.44 crores, while non-controlling interest accounted for Rs 2.54 crores. The increase in PAT includes a one-time deferred tax credit of Rs 239.48 crores on account of the company opting for the new tax regime under section 115BAA of the Income Tax Act, 1961, effective FY2026-27.

Q4 Consolidated Financial Highlights

For the fourth quarter, DCM Shriram's consolidated net profit more than doubled to Rs 370.80 crores compared to Rs 178.91 crores in the same period of the prior year. Consolidated revenue for the quarter rose to Rs 3,373.03 crores from Rs 3,019.32 crores in the corresponding period. However, EBITDA for Q4 declined to Rs 399.64 crores from Rs 426.51 crores year-on-year, with the EBITDA margin contracting to 10.48% from 13.45% in the prior-year quarter.

Metric: Q4 FY26 Q4 FY25 Net Profit (Rs. Crores) 370.80 178.91 Revenue from Operations (Rs. Crores) 3,373.03 3,019.32 EBITDA (Rs. Crores) 399.64 426.51 EBITDA Margin (%) 10.48% 13.45%

Consolidated Financial Performance

The company's consolidated financials for FY26 reflect broad-based revenue growth and improved profitability. Total revenue from operations rose to Rs 14,263.91 crores from Rs 12,741.32 crores in the prior year, representing a growth of 12%. Profit before exceptional item and tax stood at Rs 1,015.65 crores, compared to Rs 909.41 crores previously. EBITDA for the year increased to Rs 1,693.67 crores from Rs 1,472.40 crores. Earnings per equity share (after exceptional item) on a consolidated basis stood at Rs 54.73, compared to Rs 38.75 in the prior year. Net Worth stood at Rs 7,660.29 crores.

Metric: FY26 (Audited) FY25 (Audited) Total Revenue from Operations (Rs. Crores) 14,263.91 12,741.32 Profit Before Exceptional Item & Tax (Rs. Crores) 1,015.65 909.41 Profit After Tax (Rs. Crores) 855.98 604.27 EBITDA (Rs. Crores) 1,693.67 1,472.40 EPS – After Exceptional Item (Rs.) 54.73 38.75

Standalone Financial Performance

On a standalone basis, total revenue from operations for FY26 was Rs 13,796.72 crores, compared to Rs 12,441.96 crores in the prior year. Standalone PAT for the year was Rs 837.55 crores versus Rs 566.53 crores previously. Standalone EBITDA for FY26 was Rs 1,639.53 crores, up from Rs 1,409.85 crores. Standalone profit before exceptional item and tax was Rs 984.91 crores against Rs 858.29 crores in the prior year. The standalone results include an exceptional item related to the statutory impact of new Labour Codes. The company had made an additional provision of Rs 55 crores during the quarter and nine months ended December 31, 2025. Following a detailed review during the quarter ended March 31, 2026, the impact was reduced and Rs 31.62 crores was reversed, resulting in a net exceptional item of Rs 23.38 crores for the year.

Metric: FY26 (Audited) FY25 (Audited) Total Revenue from Operations (Rs. Crores) 13,796.72 12,441.96 Profit Before Exceptional Item & Tax (Rs. Crores) 984.91 858.29 Profit After Tax (Rs. Crores) 837.55 566.53 EBITDA (Rs. Crores) 1,639.53 1,409.85

Segment-wise Performance

Across business segments, Chemicals and Vinyl was the largest revenue contributor, with segment revenue of Rs 4,650.99 crores in FY26 compared to Rs 3,562.25 crores in the prior year. Sugar and Ethanol contributed Rs 4,496.17 crores versus Rs 4,525.76 crores, operating in a challenging environment marked by higher cane prices and oversupply conditions. Shriram Farm Solutions reported segment revenue of Rs 1,689.08 crores against Rs 1,436.37 crores, a growth of 18%. Fenesta Building Systems grew to Rs 1,112.20 crores from Rs 868.46 crores, a growth of 28%.

Segment: FY26 Revenue (Rs. Crores) FY25 Revenue (Rs. Crores) Chemicals and Vinyl 4,650.99 3,562.25 Sugar and Ethanol 4,496.17 4,525.76 Fertiliser 1,444.80 1,461.20 Shriram Farm Solutions 1,689.08 1,436.37 Fenesta Building Systems 1,112.20 868.46 Bioseed 665.80 647.86 Others 286.41 306.51

Dividend and Corporate Actions

The Board recommended a final dividend of Rs 4.00 per equity share of face value Rs 2 each (200%) for FY2025-26, amounting to Rs 62.38 crores, subject to shareholder approval at the 37th Annual General Meeting scheduled for August 18, 2026. Including the first and second interim dividends of Rs 3.60 per share each declared earlier, the total dividend for FY2025-26 aggregates to Rs 11.20 per equity share (560%), amounting to Rs 174.66 crores in total. The Board also approved, subject to shareholder approval, the cancellation of 39,00,000 forfeited equity shares of Rs 2 each.

Subsidiary Developments and Capital Expenditure

The Board approved financial assistance of up to Rs 100 crores to Hindusthan Speciality Chemicals Limited (HSCL), a wholly owned subsidiary, to support a capital investment of Rs 101 crores aimed at augmenting HSCL's Formulated Resins capacity by 36K TPA, reaching a total capacity of 50K TPA. HSCL reported a turnover of Rs 252.73 crores and a PAT of Rs (48.03) crores for FY26. The indicative time period for completion of the investment is September 30, 2027.

Parameter: Details Subsidiary Hindusthan Speciality Chemicals Limited (HSCL) Financial Assistance Up to Rs 100 crores (mix of Equity & Debt) Capital Investment Rs 101 crores Capacity Addition 36K TPA Formulated Resins Total FR Capacity Post-Expansion 50K TPA HSCL Turnover (FY26) Rs 252.73 crores HSCL PAT (FY26) Rs (48.03) crores Completion Timeline September 30, 2027

Separately, the company executed a Joint Venture Agreement with Teknor Apex B.V. on April 16, 2026, and sold its 50% equity stake in Shriram Polytech Limited, which consequently ceased to be a subsidiary and became a Joint Venture effective April 17, 2026. The company also commissioned the balance capacity of 17,000 TPA of Epichlorohydrin (ECH) at its chemical complex in Jhagadia, Gujarat on April 01, 2026, bringing the total ECH capacity to 52,000 TPA.

We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.

Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.

As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation.

We plan to change that - a technology-led and artificial intelligence enabled platform built for super traders and long term investors.

Disclaimer:

The data and information provided on this website is for general informational and research purposes only. While we strive to ensure that the content is accurate, up-to-date, and reliable, this platform utilizes artificial intelligence (AI) tools to generate, curate, and summarize information. As such, the content may occasionally contain errors, omissions, or outdated information. All users are therefore advised to cross verify the source of the data and information.

This website does not constitute professional, legal, financial, medical, or any other form of licensed advice. Users are encouraged to independently verify any information before relying on it, especially for decisions that may have legal, financial, or personal consequences.

The views, analyses, and summaries presented on this platform may be generated or assisted by AI and do not necessarily reflect the opinions of the website owners, operators, editors, or affiliates.

We make no warranties or representations, express or implied, regarding the completeness, accuracy, reliability, suitability, or availability of the information contained on this website. Any reliance you place on such information is strictly at your own risk.

This website may include links to third-party sources or content. We do not control or endorse the nature, accuracy, or availability of those external sites and are not responsible for any content or damages arising from their use.

By using this website, you acknowledge and agree that the use of AI-generated content involves inherent limitations, uncertainties and inaccuracies, and you accept full responsibility for how you interpret and use the information provided.

We reserve the right to modify, update, or remove content and this disclaimer at any time without prior notice.